Access1 Access2 Access3 Medication & Drugs Skin February 17, 2022 HSA approves the first JAK inhibitor for moderate-to-severe atopic dermatitis: baricitinib (Olumiant)
Infectious Disease Medication & Drugs February 8, 2022 Current Oral Drugs Available for COVID-19 Treatment